Seagen Talks Up 24% Growth, Not About Speculated Merck Buyout

Daiichi Arbitration Is Another Wildcard

 
• By Alaric DeArment
Like Merck before it, Seagen kept quiet about a speculated buyout deal between the two companies • Source: Shutterstock

More from Earnings

More from Business